Results

Total Results: 1,952 records

Showing results for "agency".

101. Draft Modeling Report: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-modeling-report/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
     October 12, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

102. Draft Evidence Review: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
     October 12, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

103. Draft Evidence Review: Screening for Impaired Visual Acuity in Older Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/impaired-visual-acuity-screening-older-adults
     October 26, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

104. Draft Evidence Review: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/statin-use-primary-prevention-cardiovascular-disease-adults
     February 22, 2022 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

105. Draft Evidence Review: Syphilis Infection in Nonpregnant Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/syphilis-infection-nonpregnant-adults-adolescents-1
     February 15, 2022 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

106. Draft Evidence Review: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/screening-anxiety-children-adolescents
     April 12, 2022 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

107. Draft Evidence Review: Prediabetes and Type 2 Diabetes in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/prediabetes-type2-diabetes-children-adolescents-screening
     December 14, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

108. Draft Evidence Review: Depression and Suicide Risk in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/screening-depression-suicide-risk-children-adolescents
     April 12, 2022 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

109. Literature Surveillance Report: Iron Deficiency Anemia in Young Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/literature-surveillance-report-/iron-deficiency-anemia-in-young-children-screening
     December 01, 2020 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

110. Literature Surveillance Review: Gynecological Conditions: Periodic Screening With the Pelvic Examination | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/literature-surveillance-review/gynecological-conditions-screening-with-the-pelvic-examination
     June 21, 2022 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

111. Final Evidence Review: Atrial Fibrillation: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/atrial-fibrillation-screening
     January 25, 2022 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

112. Final Evidence Review: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/colorectal-cancer-screening
     May 18, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

113. Final Evidence Review: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/skin-cancer-screening
     April 18, 2023 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

114. Final Evidence Review: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/chlamydia-and-gonorrhea-screening
     September 14, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

115. Final Evidence Review: Hypertension in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/hypertension-in-adults-screening
     April 27, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

116. Final Evidence Review: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/genital-herpes-serologic-screening
     February 14, 2023 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

117. Draft Evidence Review: Prevention of Dental Caries in Children Younger Than 5 Years: Screening and Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/prevention-of-dental-caries-in-children-younger-than-age-5-years-screening-and-interventions1
     May 11, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

118. Draft Evidence Review: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/prediabetes-and-type-2-diabetes-mellitus-screening
     March 16, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

119. Draft Evidence Review: Screening for Prediabetes and Type 2 Diabetes | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/prediabetes-and-type-2-diabetes-screening
     March 16, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality

120. Draft Evidence Review: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     May 04, 2021 - They should not be construed as an official position of the Agency for Healthcare Research and Quality